1
0
0
(1 - 26 von 40
)
Mit Arzneimittelvielfalt gegen die ResistenzproblematikBAH Bonn
www.bah-bonn.de
Robert Welte, Head of new products & health outcomes, Glaxo SmithKline GmbH & Co. KG (GSK). Zudem findet eine Podiumsdiskussion zur Fragestellung „Ermöglicht ... Robert Welte, Head of new products & health outcomes, Glaxo SmithKline GmbH & Co. KG (GSK). Zudem findet eine Podiumsdiskussion zur Fragestellung „Ermöglicht ...
PLG » 8th European Pharma Licensing Symposium
plg-group.com
Germany - ROBERT WELTE, Head of Market Access, GSK Pharma Germany Italy - LIVIO GARATTINI, Director, Centre for Health Economics (CESAV)
Healthcare Resource Utilization and Cost of Patients with ...RePEc: Research Papers in Economics
ideas.repec.org
von Z Kocaata · · Zitiert von: 4 — Robert Welte. (GlaxoSmithKline GmbH & Co. KG). Hermann Einsele. (Zentrum Innere ... Suggested Citation. Zeki Kocaata & Thomas Wilke & Franz Fischer & Robert Welte ... von Z Kocaata · · Zitiert von: 4 — Robert Welte. (GlaxoSmithKline GmbH & Co. KG). Hermann Einsele. (Zentrum Innere ... Suggested Citation. Zeki Kocaata & Thomas Wilke & Franz Fischer & Robert Welte ...
Epidemiology, treatment and health care resource use of ...Taylor & Francis Online
www.tandfonline.com
von F Hardtstock · · Zitiert von: 2 — Marco Lukas, Bernhard Ultsch and Robert Welte are GSK employees and shareholders. Renate Quinzler is an employee of AOK Baden-Württemberg and has nothing to ... von F Hardtstock · · Zitiert von: 2 — Marco Lukas, Bernhard Ultsch and Robert Welte are GSK employees and shareholders. Renate Quinzler is an employee of AOK Baden-Württemberg and has nothing to ...
Methodological Advances in the Economic Goodreads
www.goodreads.com
— Robert Welte · Rating details · 0 ratings · 0 reviews. Currently, most health care systems cannot afford all possible health care ... › show
Methodological Advances in the Economic... de Robert Welte - Livrewww.decitre.fr › ... › Economie & finances
www.decitre.fr
The Author : Robert Welte graduated in from the University of Ulm with a Ph.D. in human biology with a focus on health economics.
Statistics for Biology and Health - Hugendubel
media.hugendubel.de
WEBRobert Welte, Reiner Leidl, Wolfgang Greiner, and Maarten Postma Part III Epidemiology of Particular Infectious Diseases 16 Airborne Transmission: Influenza and Tuberculosis.....
Cost‐Effectiveness of Partner Pharmacotherapy in ...Wiley Online Library
onlinelibrary.wiley.com
von MJ Postma · · Zitiert von: 32 — Robert Welte MSc. Department for Health Services Research, National Institute of Public Health and the Environment, Bilthoven, ...
Moral Hazard and Cash Benefits in Long-Term Home Care
docs.iza.org
WEBRobert Welte, and Joshua Wiener for useful comments on an earlier draft of this paper, as well as the participants of a iBMG seminar in and the Fifth European Health Economics …
Statistics for Biology and Health
download.e-bookshelf.de
WEBRobert Welte, Reiner Leidl, Wolfgang Greiner, and Maarten Postma Part III Epidemiology of Particular Infectious Diseases 16 Airborne Transmission: Influenza and Tuberculosis.....
Die volkswirtschaftlichen Kosten des Zigarettenrauchens in Deutschland
www.degruyter.com
Simone Neubauer / Robert Welte / Hans-Helmut König / Reiner Leidl. Citation Information: Public Health Forum. Volume 15, Issue 1, Pages 22–25, ISSN (Online) …
Public Health Forum | Rauchen | ScienceDirect.com by Elsevier
www.sciencedirect.com
Reiner Leidl, Simone Neubauer, Robert Welte, Hans-Helmut König. Pages : Download PDF. select article Auswirkungen von Tabaksteuererhöhungen in ...
Vol. 1, No. 2, of Health Economics in Prevention jstor
www.jstor.org
Maarten Postma, Robert Welte, Anneke van den Hoek, Gerard van Doornum, Dieke Mulder-Folkerts, Roel Coutinho and Hans Jager. https://www.jstor.org/stable › stable
Cost impact of prospective HLA-B*5701-screening prior to...
eurjmedres.biomedcentral.com
Robert Welte and Monika Baudewig are employees of GlaxoSmithKline, Germany. Ravi Walli is an employee of ViiV Healthcare, Germany.
Cost-effectiveness of screening asymptomatic women for ...Springer
link.springer.com
von M Postma · · Zitiert von: 12 — Robert Welte & Hans Jager. Municipal Health Service, Amsterdam, the NetherlandsNL. Anneke van den Hoek, Dieke Mulder-Folkerts & Roel Coutinho. von M Postma · · Zitiert von: 12 — Robert Welte & Hans Jager. Municipal Health Service, Amsterdam, the NetherlandsNL. Anneke van den Hoek, Dieke Mulder-Folkerts & Roel Coutinho.
Health Economics of Infectious Diseases | SpringerLink
link.springer.com
Due to technical innovations and demographic changes, many industrialized countries are facing problems in financing health-care costs. One way to guide...
Robert WelteGoogle Scholar
scholar.google.com
Robert Welte. Gilead Sciences. Verified email at gilead.com. economic evaluationhealth economicsmarket accessmodellingquality of life. Articles ... Robert Welte. Gilead Sciences. Verified email at gilead.com. economic evaluationhealth economicsmarket accessmodellingquality of life. Articles ...
Robert Welte's research works | Fichtner GmbH & Co. KG ...ResearchGate
www.researchgate.net
Robert Welte's 9 research works with 20 citations and 269 reads, including: Epidemiology, Treatment and Health Care Resource Use of Patients with severe ... Robert Welte's 9 research works with 20 citations and 269 reads, including: Epidemiology, Treatment and Health Care Resource Use of Patients with severe ...
Association between asthma control and healthcare costsSage Journals
journals.sagepub.com
von T Wilke · — Victoria Unmuessig and Robert Welte are GSK employees and hold stocks and shares. Ulf Maywald has no potential conflict of interest, except those ...
Chlamydia screening is not cost-effective at low ...Instituut voor Tropische Geneeskunde
research.itg.be
... Robert Welte, Eline L M Op de Coul, Mirjam E Kretzschmar. Department of Public Health. Research output: Contribution to journal › A1: Web of Science-article Robert Welte, Eline L M Op de Coul, Mirjam E Kretzschmar. Department of Public Health. Research output: Contribution to journal › A1: Web of Science-article ...
Direct Cost Analysis of Intensive Care Unit Stay in Four ...Value in Health
www.valueinhealthjournal.com
von SS Tan · · Zitiert von: 190 — Robert Welte, PhD. Robert Welte. Affiliations. GlaxoSmithKline, New Products & Health Outcomes, Munich, Germany. Search for articles by this author. Leona ... von SS Tan · · Zitiert von: 190 — Robert Welte, PhD. Robert Welte. Affiliations. GlaxoSmithKline, New Products & Health Outcomes, Munich, Germany. Search for articles by this author. Leona ...
Health Economics of Infectious DiseasesInfona.pl
www.infona.pl
von R Welte · Zitiert von: 10 — Robert Welte. Institute of Health Economics and Health Care Management (IGM), Helmholtz Zentrum München, German Research Center for Envir…
Health-related quality of life (HRQoL) in German early ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von L Kramer — Robert Welte , Marc Esser. Affiliations. 1 co.value, Deutschland. Electronic address: . 2 Pharm-Analytics GmbH, Hamburg ... von L Kramer — Robert Welte , Marc Esser. Affiliations. 1 co.value, Deutschland. Electronic address: . 2 Pharm-Analytics GmbH, Hamburg ...
Tobacco. The costs of health damage and productivity ...OA.mg
oa.mg
Robert Welte,Hans-Helmut König,Reiner Leidl. Internal medicine. Cigarette smoking. Environmental health European journal of public health →.
costs of health damage and productivity losses attributable to ...Oxford Academic
academic.oup.com
von R WELTE · · Zitiert von: 160 — The costs of health damage and productivity losses attributable to cigarette smoking in Germany. ROBERT WELTE ,. ROBERT WELTE. Department of Health Economics ... von R WELTE · · Zitiert von: 160 — The costs of health damage and productivity losses attributable to cigarette smoking in Germany. ROBERT WELTE ,. ROBERT WELTE. Department of Health Economics ...
Alle Infos zum Namen "Robert Welte"
sortiert nach Relevanz / Datum